These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 8799169

  • 1. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA.
    Proc Natl Acad Sci U S A; 1996 Aug 20; 93(17):9148-53. PubMed ID: 8799169
    [Abstract] [Full Text] [Related]

  • 2. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, Wasik MA.
    Leuk Res; 1999 Apr 20; 23(4):373-84. PubMed ID: 10229324
    [Abstract] [Full Text] [Related]

  • 3. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
    Wasik MA, Nowak I, Zhang Q, Shaw LM.
    Leuk Lymphoma; 1998 Feb 20; 28(5-6):551-60. PubMed ID: 9613985
    [Abstract] [Full Text] [Related]

  • 4. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
    Nielsen M, Svejgaard A, Röpke C, Nordahl M, Odum N.
    Proc Natl Acad Sci U S A; 1995 Nov 21; 92(24):10995-9. PubMed ID: 7479924
    [Abstract] [Full Text] [Related]

  • 5. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL.
    J Immunol; 2000 Nov 01; 165(9):5097-104. PubMed ID: 11046040
    [Abstract] [Full Text] [Related]

  • 6. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
    Kirken RA, Rui H, Malabarba MG, Howard OM, Kawamura M, O'Shea JJ, Farrar WL.
    Cytokine; 1995 Oct 01; 7(7):689-700. PubMed ID: 8580378
    [Abstract] [Full Text] [Related]

  • 7. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
    Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, Gouilleux F, Groner B, Ihle JN, Minami Y, Miyazaki T.
    Proc Natl Acad Sci U S A; 1995 Jun 06; 92(12):5482-6. PubMed ID: 7777534
    [Abstract] [Full Text] [Related]

  • 8. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS, Jun HS, Utsugi T, Yoon JW.
    J Autoimmun; 1997 Jun 06; 10(3):299-307. PubMed ID: 9218758
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
    Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8705-9. PubMed ID: 7568001
    [Abstract] [Full Text] [Related]

  • 11. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL.
    J Immunol; 1999 Apr 01; 162(7):3897-904. PubMed ID: 10201908
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC, Smiers F, Pouwels K, Hoefsloot LH, Löwenberg B, Touw IP.
    Leukemia; 1996 Aug 01; 10(8):1317-25. PubMed ID: 8709637
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
    Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N.
    Leukemia; 2001 May 01; 15(5):787-93. PubMed ID: 11368440
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
    Cheng J, Zhang D, Zhou C, Marasco WA.
    Leuk Res; 2004 Jan 01; 28(1):71-82. PubMed ID: 14630083
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
    Lischke A, Moriggl R, Brändlein S, Berchtold S, Kammer W, Sebald W, Groner B, Liu X, Hennighausen L, Friedrich K.
    J Biol Chem; 1998 Nov 20; 273(47):31222-9. PubMed ID: 9813029
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
    Bianchi M, Meng C, Ivashkiv LB.
    Proc Natl Acad Sci U S A; 2000 Aug 15; 97(17):9573-8. PubMed ID: 10920190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.